- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.21: 2 residues within 4Å:- Chain A: F.59, N.61
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: N.616, T.618
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.709, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: N.164, N.165
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain A: F.338, F.342, N.343, L.368
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.122, V.127
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.280, N.282
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.616
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: D.796
- Chain B: N.709, G.1131
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: F.338, G.339, N.343
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: F.338, G.339, N.343
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.234
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.616
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain C: N.165
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mikolajek, H. et al., Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-07-13
- Peptides
- Spike glycoprotein,Fibritin: ABC
Nanobody H11-H6: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
FE
DF
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mikolajek, H. et al., Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-07-13
- Peptides
- Spike glycoprotein,Fibritin: ABC
Nanobody H11-H6: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
FE
DF
E